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ABSTRACT The mass-weighted molecular dynamics simulation method was developed previously for sampling the multidimen-
sional conformational space of linear and cyclic polypeptides and studying their conformational flexibility. Herein results from
molecular dynamics simulations of the protein-ligand complex of the aspartyl protease rhizopuspepsin and a polypeptide inhibitor
are reported. The dihedral conformational space sampling for the linear peptide inhibitor in situ was found to be increased in the
mass-weighted simulation as in other molecular systems previously studied. More significantly, the physical space of the enzyme
binding pocket was also sampled efficiently in the simulations and multiple binding sites were identified for the inhibitor. These
results suggest that it may be possible now to study, by computer simulations, the putative initial enzyme-inhibitor complex
suggested experimentally from the time-dependent kinetics of enzyme inhibition by slow-binding inhibitors (Morrison, J. F., and C.
T. Walsh. 1988. Adv. Enzymol. 61:201), and/or conformational substates in protein-ligand complexes suggested in the study of
reassociation dynamics of myoglobin and carbon monoxide following photolysis (Austin, R. H., K. W. Beeson, L. Eisenstein, H.
Frauenfelder, and 1. C. Gunsalus. 1975. Biochemistry. 14:5355). Moreover, the intermediate binding steps and the molecular
flexibility of the inhibitor shown in the MWMD simulation may have crucial roles in the ligand binding process.
INTRODUCTION
Proteins are intrinsically flexible molecules (Debrunner
and Frauenfelder, 1982; Wagner and Wuthrich, 1986).
The large number of internal degrees of freedom due to
the large number of constituent atoms in proteins also
results in complex potential energy surfaces and com-
plex atomic motions (Frauenfelder et al., 1979) and
protein-ligand interactions (Austin et al., 1975). On the
other hand, dynamics of internal motions of these
molecules over a wide range of magnitude and time
scale, as well as other problems in protein structure and
function, have been studied by a variety of computer
simulation methods (McCammon and Harvey, 1987;
Brooks et al., 1988; Karplus and Petsko, 1990). For
example, results from molecular dynamics simulations
showed that atomic motion can be highly complex
(Northrup et al., 1981; Mao et al., 1982; Ichiye and
Karplus, 1987); collective and large scale structural
changes have also been studied (McCammon et al.,
1977; Northrup et al., 1982; Mao and McCammon,
1983).
Due to the large number of degrees of freedom in a
biomacromolecular system, the sampling of the multidi-
mensional conformational space in molecular dynamics
simulations is restricted to the local region near the
initial conformation. Usually a crystallographically deter-
mined high resolution molecular structure of the protein
is used as the starting structure in these simulations.
Even for short polypeptide molecules, the conforma-
tional search may be limited in certain situations (Mao
and Friedman, 1990). The mass-weighted molecular
dynamics (MWMD) simulation method has been ap-
plied to the investigation of the conformational flexi-
bility in small linear polypeptides (Mao and Friedman,
1990; Mao, 1991) and cyclic and pseudocyclic molecules
(Mao et al., 1991). In these simulations, atomic masses
in the molecular system were multiplied uniformly by a
numerical weighting factor w (w > 1.0); rigid internal
degrees of freedom of the system (i.e., covalent bonds,
bond angles, amide planes, and chiral carbon centers)
were maintained by constraints such that these struc-
tural features do not become distorted during mass-
weighted molecular dynamics simulations. In the other-
wise standard molecular dynamics simulation, potential
energy surface in the "soft" degrees of freedom (e.g.,
dihedral rotations and nonbonded interactions, which
confer molecular flexibility) is not altered by these
constraints and energy barriers are thereby overcome
more readily due to large effective momenta of the
particles. The mass-weighting scheme has an advantage
over the high-temperature scheme in that a large value
can be used for w and atomic velocities can remain in the
regime in which the MD integration maintains numeri-
cal stability. In comparison with normal-mass molecular
dynamics (NMMD) simulations, the full 3600 range of
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individual backbone dihedral angles 4s and J's in a
linear polypeptide was sampled thoroughly when the
atomic masses were weighted from their respective
normal values; moreover, the correlation of the values of
+ and 4 torsional angles (4+-* plot) of individual amino
acid residues in the MWMD simulation shows that the
underlying potential energy surface is consistent with
the adiabatic potential energy contours in Ramachan-
dran plots and not affected by the constraints (Mao,
1991), and that the +-qj conformational space is effi-
ciently sampled. In simulations of pseudocyclic mole-
cules, the extensive sampling of the physical space about
the fixed points in MWMD suggests that the method can
generate polypeptide conformations for modeling pro-
tein surface loops (Mao et al., 1991).
From these earlier investigations in which NMMD
andMWMD of simple polypeptide systems were studied
comparatively, it appears that atomic mass weighting in
molecular dynamics simulations could be a general
concept for sampling conformational space of molecular
systems that contain flexible degrees of freedom such as
protein-ligand interactions in a biomolecular complex.
Results from the rhizopuspepsin-inhibitor complex in
this work indicate efficient sampling of both the internal
(dihedral angle) coordinate space and the physical space
of the binding pocket. Moreover, a secondary inhibitor
binding site was identified which may be hypothesized to
be related to the slow-binding inhibition observed for
aspartyl proteases and other enzymes. In molecular
complexes for which no structural data are available but
for which molecular models can be constructed, the
method can be employed to evaluate the stability of
binding of a proposed ligand binding geometry, and/or
to generate other potential ligand binding sites.
METHODS
For investigating the application of our MWMD simulation method to
protein-ligand complexes, the crystal structure of a fungal aspartyl
protease, rhizopuspepsin, complexed with a polypeptide inhibitor
(Suguna et al., 1987) was chosen as a prototypical system (Fig. 1 a).
For the purpose of exploring and developing the methodology, atoms
of the enzyme were held fixed near their respective crystallographically
determined positions, with all of the crystalline water molecules
removed (see Fig. 1 for details). For comparison with the MWMD
results, a normal-mass molecular dynamics (NMMD) simulation
(Brooks et al., 1983) was first generated in which only inhibitor atoms
were allowed to move freely. In the MWMD simulation, atoms in the
polypeptide inhibitor were mass weighted and internal coordinates
were constrained as in previous MWMD studies (Mao and Friedman,
1990; Mao, 1991); details of the simulation protocols are described in
Fig. 2.
RESULTS
As shown in Fig. 2, the molecular dynamics integration
has yet to reach equilibration after 200 ps of NMMD
simulation under the conditions prescribed for this set of
simulations; in contrast, the MWMD simulation became
"equilibrated" at 75 ps, and the total energy of system
remained essentially constant as expected for microca-
nonical ensembles generated from molecular dynamics
simulations. The sampling of the full 3600 range for a
representative backbone dihedral angle and that for a
representative sidechain dihedral angle during the two
simulations are shown in Fig. 3. The sampling of the
dihedral angle space can be summarized in Table 1 in
which two indicators for the range and the coverage of
the conformational sampling (Mao et al., 1991) were
computed for unconstrained dihedral angles in the
backbone (k's and 4i's) and the sidechain (xl's) in the
two simulations; the significant improvement in the
sampling in MWMD is shown by the higher values of
both indicators from the MWMD simulation than those
from the NMMD simulation.
In addition to the improved sampling of internal
dihedral angle degrees of freedom in MWMD, the
sampling of physical space in the binding pocket is also
increased in the mean time. The position of the Ca atom
in Phe5 of the inhibitor during the normal-mass MD
simulation is shown in Fig. 4; in contrast, the position
distribution not only becomes broadened in MWMD,
but also shows two preferred locations in the binding
pocket for this backbone atom (Fig. 5 a). Of these two
preferred locations for the inhibitor, the primary site is
located near the crystallographic position, and the sec-
ondary site (with a lower population) is located between
the primary binding site and the opening of the binding
pocket. The position distribution of C-y of Phe5 (Fig. 5 b)
shows that the sidechain group also has two preferred
locations, indicating that there are two specificity pock-
ets for this residue. At the secondary binding site located
near the exit to the solvent space, the kinetically ener-
gized inhibitor was in fact able to assume conformations
that are required for eventually reaching the opening
and escaping the enzyme binding pocket (Fig. 6). In the
MWMD simulation in which the opening of the binding
pocket was blocked by water molecules, which as a first
approximation were kept fixed in their respective spatial
positions as protein atoms were, the inhibitor molecule
was, as expected, prevented from leaving the binding
pocket; moreover, the same set of primary and second-
ary binding sites were also identified (data not shown).
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FIGURE 1 (a) Schematic drawing of the peptide inhibitor D-His-Pro-Phe-His-PheT[CH2-NH]Phe-Val-Tyr. Each arrow indicates a dihedral angle
that is allowed to freely rotate during simulations, except dihedral angle #18 which is monitored for proline ring conformation. All proper dihedral
angles of sidechains are allowed to rotate; only xl's are explicitly indicated here. (b) Schematic representation of ligand binding region of the
rhizopuspepsin-inhibitor complex, in stereoscopic images. The enzyme and the inhibitor are represented by the Ca tracing; sidechain groups are
present in the simulations but not explicitly drawn here. The Ca atom of Phes of the inhibitor and the Ca atoms of the catalytic residues of
rhizopuspepsin, Asp35 and AsP218, are marked with small squares. The scale on the upper right corner is a 5-A bar for reference. In the
crystallographically determined structure of the complex, the two terminal residues of the inhibitor did not have well-defined positions. Atomic
coordinates for these two residues were first generated by standard geometry of the two residue types (Mao, unpublished data); the positions of
their backbone and sidechains were then optimized by rigid rotation of the backbone and side-chain dihedral angles. Crystalline water molecules
were then removed, and the complex energy minimized so that the molecular dynamics simulation could be started without extreme initial atomic
velocities; the RMS position difference between the energy-minimized structure of the complex and the crystallographic coordinate set is 0.16 A.
DISCUSSION
The results presented above showed the advantage of
the MWMD method over the normal-mass MD simula-
tion in sampling the conformational space of the ligand
molecule in the complex. The system becomes equili-
brated more rapidly. The sampling of internal and
external degrees of freedom of the ligand is significantly
increased; the sampling of the physical space of the
binding pocket appears to be coupled to the sampling of
dihedral conformational space in that the latter allows
the inhibitor molecule as a whole to assume conforma-
tions that are significantly different from the crystallo-
graphic structure and thereby explore other binding
geometries within the enzyme binding pocket. During
the MWMD simulation, the inhibitor overcomes a
potential energy barrier that apparently exists between
the primary and the secondary binding sites. Moreover,
the sampling of the conformational space for the inhibi-
tor is such that, in the simulation in which the bulk
solvent is not explicitly represented and the inhibitor
molecule is energized kinetically by the weighting of
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FIGURE 2 Total energy of MWMD (upper curve) and normal MD (lower curve) simulations. The simulation step is 0.9766 fs. Nonbonded
interatomic interactions were cutoff at 8.0 A and hydrogen-bond interactions were cutoff at 6.0 A, and distance-dependent dielectric constant was
used for electrostatic interactions; lists of hydrogen-bond and nonbonded atom pairs were regenerated at every 20 steps. The system was
thermalized during the first 20 ps by heating in 30-K increments at 0.5-ps intervals, followed by reequilibrations at 0.5-ps intervals; the final nominal
equivalent system temperature is 600 K for both simulations. The mass weighting factor for the inhibitor atoms is 30.0 in the MWMD simulation;
harmonic potentials were set at 10,000.0 Kcal/mol_A2 for constraining covalent bonds, 4,000.0 Kcal/mol-rad2 for valence angles, and 400.0
Kcal/mol-rad2 for improper dihedral angles and amide planes.
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FIGURE 3 Distribution of numerical values in the 360° range for two of the dihedral angles shown in Fig. 1 a; (a) for dihedral angle #12, (b) for
#22. For each dihedral angle, the 360° space is divided into 1 bins and number of time steps at which the dihedral angle has the numerical value at
each bin is counted for the length of an MD simulation and plotted against the 360 bins. For each dihedral angle, the curve in thick line is obtained
from the 200 ps normal mass molecular dynamics simulation, and the curve in thin line is obtained from the first 100 ps mass-weighted MD
simulation. See Table 1 for details of the statistics for all dihedral angles shown in Fig. 1 a.
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TABLE 1 The range and the coverage of backbone and
sidechaln dihedral angle space of
D-His-Pro-Phe-His-Phe'I[CH2-NH]Phe-Val-Tyr In normal-mass
MD (1-200 ps) and mass-weighted MD (1-100 ps)
simulations
NMMD MWMD ratio
(R) (C) (R) (C) (R) (C)
1 223 10.04 323 28.80 1.45 2.87
2 92 7.53 158 14.73 1.72 1.95
3 98 9.97 359 34.10 3.66 3.42
4 83 7.28 356 24.00 4.29 3.30
5 73 6.64 302 25.41 4.14 3.82
6 72 6.82 309 20.90 4.29 3.06
7 101 11.27 321 22.73 3.18 2.02
8 79 7.24 305 17.75 3.86 2.45
-9 100 -6.75 296 21.24 2.96 3.15
10 93 6.78 219 22.73 2.35 3.35
11 116 7.20 312 27.00 2.69 3.75
12 76 6.86 360 34.10 4.74 4.97
13 114 13.22 358 35.99 3.14 2.72
14 103 9.82 352 25.92 3.42 2.64
15 134 10.71 360 46.28 2.69 4.32
16 342 30.14 360 46.28 1.05 1.54
17 181 10.13 359 35.99 1.98 3.56
18 111 7.16 73 6.86 0.66 0.96
19 97 8.36 350 22.73 3.61 2.72
20 170 13.09 347 26.44 2.04 2.02
21 80 6.58 271 20.90 3.39 3.18
22 67 6.23 306 27.00 4.57 4.33
23 169 9.60 358 33.23 2.12 3.46
24 142 8.25 343 22.73 2.42 2.75
For either simulation, the range (R) and the coverage (C) indicators are
computed for each dihedral angle as labeled in Fig. 1 a. From the
distribution of numerical values in the full 3600 range for a given
dihedral angle in either NMMD or MWMD, such as those shown in
Fig. 3, R is the number of 10 bins in the 3600 range that are occupied
(i.e., the number of points along thex-axis that have nonzeroy-values);
C is defined as the percentage of the rectangular area (from 0 to 360 in
the x-axis, and from 0 to the maximum y-value for the curve in the
y-axis) that is under the curve. The C indicator has a minimum value of
0.278% (1/360) for an extremely narrow distribution, and a maximum
value of 100.0% for an entirely uniform distribution. The ratios in R
and C (MWMD value/NMMD value) are also listed for each dihedral
angle.
atomic masses, the inhibitor, while in the secondary
binding site, was able to locate the opening of the
binding pocket and assume conformations suitable for
negotiating the path for leaving the binding pocket.
The absence of solvent bulk and the rigidity of the
enzyme binding pocket in the present study obviously
require more sophisticated treatments. The description
of the primary and the secondary binding sites for
inhibitors of aspartyl proteases presented here neverthe-
less may remain unchanged when these factors are
included in the simulation, for the following reasons.
Position flcations of atoms in a protein are estimated,
both experimentally and theoretically, to be generally on
the order of 0.7 A (Northrup et al., 1982). Because the
binding sites are 3-4 A in size and are separated by a
distance of 4-5 A (Fig. 5), the flexibility of the enzyme
binding pocket due to atomic position fluctuations on
the order of 0.7 A will be expected to modulate some-
what, but not alter dramatically, the potential energy
surface and the two binding sites revealed in the present
MWMD simulation. On the other hand, the inclusion of
fixed water molecules in the simulation prevents the
inhibitor from leaving the binding site and forces the
inhibitor to sample only the interior of the binding
pocket; still the same set of primary and secondary
binding sites were identified, without any additional
sites for the inhibitor. Thus only two such binding sites
appear to exist for certain inhibitors of aspartyl pro-
teases such as that in the bimolecular complex of
rhizopuspepsin studied here; this would be consistent
with the two-state model of slow-binding inhibition (i.e.,
initial and final enzyme-inhibitor complexes) which was
proposed from kinetics studies of slow inhibition of
aspartyl proteases (Kati et al., 1987) and other enzymes
(Morrison and Walsh, 1988). Moreover, given that these
two sites have been identified with fixed protein atoms in
the simulations, it may be hypothesized further that the
conformational change of the enzyme that might be
required for ligand binding (Morrison, 1982; Kati et at.,
1987) may have occurred before the formation of the
initial enzyme-inhibitor complex; i.e., the conforma-
tional change of the enzyme is completed on or before
the formation of the complex in which the inhibitor
binds in the secondary binding site, and the inhibitor
subsequently moves to the primary binding site in the
slow step and becomes more tightly bound without any
major conformational change of the enzyme (Fig. 5).
The secondary binding site, predicted from the crystal
structure of the complex and the sampling of the
potential energy surface at its binding pocket, can be
verified experimentally, for example, in a system in
which an extremely slow-binding inhibitor of an aspartyl
protease (Bartlett and Kezer, 1984) is cross-linked to
enzyme residues via suitable photoaffinity labels
(Chowdhry and Westheimer, 1979).
In summary, we described the mass-weighted molecu-
lar dynamics simulation of an enzyme-inhibitor complex;
results from this and previous studies using the MWMD
method show that a variety of biophysical and biochemi-
cal problems in the structure and function of biomacro-
molecular systems can be approached by this molecular
dynamics-based simulation method. With a more sophis-
ticated treatment of solvent effects and enzyme binding
site flexibility, it may also become possible to study
protein conformational substates in ligand binding (Aus-
tin et al, 1975; Frauenfelder et aL, 1988) as well as the
970 Biophysical Journal Volume 60 October 1991Biophysical Journal Volume 60 October 1991
FIGURE 4 Trajectory of atomic position, in stereoscopic images, for the Ca atom of Phe5 in the inhibitor shown in Fig. 1 a during normal mass MD
simulation. The enzyme binding pocket and the initial inhibitor structure are shown in thick lines. Similarly tight distributions are observed for
other Ca atoms of the inhibitor, except for Val at the amino and Tyr at the carboxyl terminus.
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FIGURE 5 (a) Trajectory of atomic position for the Ca atom of Phe5 in the inhibitor during the period from 70 to 120 ps ofMWMD simulation.
Two preferred locations in the binding pocket are identified for this atom. The Ca atoms of the four central residues, from His to Val, also have two
preferred locations, whereas terminal residues have one but generally broad distribution. (b) Trajectory of atomic position for the Cy atom of Phe5.
-S
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FIGURE 6 Trajectory of atomic position for the Ca atom of Phe5 in the inhibitor during the period from 20 to 130 ps ofMWMD simulation. The
three structures of the inhibitor located outside of the binding pocket are extracted from the MWMD simulation at 123.82, 127.02, and 129.82 ps,
respectively; the amino terminal of the inhibitor is pointing downward. The last structure is located - 40A away from the binding site.
role of such substates in ligand binding kinetics. As a
practical note, for many enzyme-ligand complexes for
which structural data (e.g., NMR spectroscopy, x-ray
crystallography) are not available but for which molecu-
lar models have been constructed, it has been difficult to
evaluate the accuracy of these models due to the
limitation of energy-minimization and molecular dynam-
ics simulation in sampling only the local conformational
space. The extensive conformational sampling inMWMD
simulations of a protein-ligand complex will help find
appropriate binding site(s) for the ligand, independent
of its starting conformation and physical location in the
binding pocket; alternative binding sites can be identi-
fied from the simulation results. Moreover, the interme-
diate binding steps and the molecular flexibility of the
inhibitor shown in the MWMD simulation may have
crucial roles in the ligand binding process. These consid-
erations are important factors in successful, structurally
motivated inhibitor designs.
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